Case number 1:21-cv-00695
Teva Pharmaceuticals International GmbH et al v. Dr. Reddy's Laboratories Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 27, 2023 | 146 | REDACTED VERSION of 142 Unopposed MOTION to Redact 137 Transcript by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (DiBenedetto, Emily) (Entered: 04/27/2023) (30) |
| Apr 27, 2023 | 147 | REDACTED VERSION of 143 Declaration, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (DiBenedetto, Emily) (Entered: 04/27/2023) (5) |
| Apr 24, 2023 | 144 | ORDER granting 142 Motion to Redact 142 Unopposed MOTION to Redact 137 Transcript. Signed by Judge Colm F. Connolly on 4/24/2023. (kmd) (Entered: 04/24/2023) (1) |
| Apr 24, 2023 | 145 | REDACTED VERSION OF 137 Official Transcript of Teleconference held on 3/27/2023 before Judge Colm F. Connolly. Court Reporter/Transcriber B. Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/15/2023. Redacted Transcript Deadline set for 5/25/2023. Release of Transcript Restriction set for 7/24/2023. (kmd) Modified on 4/24/2023 (kmd). (Entered: 04/24/2023) (0) |
| Apr 20, 2023 | 142 | [SEALED] Unopposed MOTION to Redact 137 Transcript - filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Text of Proposed Order)(DiBenedetto, Emily) (Entered: 04/20/2023) (0) |
| Apr 20, 2023 | 143 | [SEALED] DECLARATION re 142 Unopposed MOTION to Redact 137 Transcript [Declaration of Colman B. Ragan in Support of Plaintiffs Teva Pharmaceuticals International Gmbh and Cephalon, LLC's Unopposed Motion to Redact Transcript] by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (DiBenedetto, Emily) (Entered: 04/20/2023) (0) |
| Apr 5, 2023 | 140 | SO ORDERED, re 139 Stipulation of Dismissal, filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. CASE CLOSED. Signed by Judge Colm F. Connolly on 4/5/2023. (kmd) (Entered: 04/05/2023) (3) |
| Apr 5, 2023 | 141 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (Attachments: # 1 Stipulation of Dismissal)(kmd) (Entered: 04/05/2023) (Main Document) (3) |
| Apr 5, 2023 | 141 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (Attachments: # 1 Stipulation of Dismissal)(kmd) (Entered: 04/05/2023) (Stipulation of Dismissal) (3) |
| Apr 4, 2023 | 138 | NOTICE of Intent to Request Redaction by Nathan Roger Hoeschen re 137 Transcript (Hoeschen, Nathan) (Entered: 04/04/2023) (2) |
| Apr 4, 2023 | 139 | STIPULATION of Dismissal with Prejudice by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (DiBenedetto, Emily) (Entered: 04/04/2023) (3) |
| Mar 31, 2023 | 137 | [SEALED] Transcript of Telephone Conference held on March 27, 2023 before Judge Chief Judge Connolly. (nmf) (Entered: 03/31/2023) (0) |
| Mar 29, 2023 | 136 | REDACTED VERSION of 134 Stipulation by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Entered: 03/29/2023) (7) |
| Mar 27, 2023 | 135 | [SEALED] SO ORDERED, re 134 [SEALED] Joint STIPULATION and Order to Stay Case by Cephalon, LLC, Teva Pharmaceuticals International GmbH. filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. Signed by Judge Colm F. Connolly on 3/27/2023.This order has been emailed to local counsel. (nmf) (Entered: 03/27/2023) (0) |
| Mar 22, 2023 | 134 | [SEALED] Joint STIPULATION and [Proposed] Order to Stay Case by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Entered: 03/22/2023) (0) |
| Mar 21, 2023 | 133 | NOTICE OF SERVICE of (1) Reply Expert Report of Dr. Jayesh Mehta Regarding Invalidity of U.S. Patent No. 9,572,887 and (2) Reply Expert Report of Neal M. Davies, Ph.D. Regarding Invalidity of U.S. Patent No. 9,572,887 filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) (Entered: 03/21/2023) (3) |
| Mar 17, 2023 | 132 | Joint STIPULATION TO EXTEND TIME to Exchange Reply Expert Reports to March 20, 2023 - filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) (Entered: 03/17/2023) (2) |
| Feb 21, 2023 | 131 | NOTICE OF SERVICE of 1. Responsive Expert Report of Dr. Bernhardt Trout, Ph.D. 2. Responsive Expert Report of Dr. John P. Leonard, M.D. filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(DiBenedetto, Emily) (Entered: 02/21/2023) (2) |
| Feb 7, 2023 | 130 | SO ORDERED, re 129 STIPULATION TO EXTEND TIME regarding Expert Discovery and Pretrial Exchange to various dates, filed by Cephalon, Inc., Cephalon, LLC, Teva Pharmaceuticals International GmbH. Signed by Judge Colm F. Connolly on 2/7/2023. (kmd) (Entered: 02/07/2023) (3) |
| Feb 6, 2023 | 129 | STIPULATION TO EXTEND TIME regarding Expert Discovery and Pretrial Exchange to various dates - filed by Cephalon, Inc., Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Entered: 02/06/2023) (3) |
| Jan 10, 2023 | 128 | NOTICE OF SERVICE of (1) Opening Expert Report of Neal M. Davies, Ph.D. Regarding Invalidity of U.S. Patent No. 9,572,887 and (2) Opening Expert Report of Dr. Jayesh Mehta Regarding Invalidity of U.S. Patent No. 9,572,887 filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) (Entered: 01/10/2023) (3) |
| Jan 6, 2023 | 127 | SO ORDERED, re 125 Stipulation regarding Infringement, filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. Ordered by Judge Colm F. Connolly on 1/6/2023. (kmd) (Entered: 01/06/2023) (6) |
| Jan 5, 2023 | 125 | Joint STIPULATION and [Proposed] Order regarding Infringement by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (DiBenedetto, Emily) (Entered: 01/05/2023) (6) |
| Jan 5, 2023 | 126 | Joint STIPULATION regarding Authenticity by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (DiBenedetto, Emily) (Entered: 01/05/2023) (4) |
| Dec 16, 2022 | 124 | NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s First Set of Interrogatories (Nos. 1 - 9) filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Keller, Karen) (Entered: 12/16/2022) (2) |
| Dec 13, 2022 | 123 | SO ORDERED, re 122 STIPULATION TO EXTEND TIME Exchange of Expert Reports to January 6, 2023, filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Resetting Scheduling Order Deadlines: Opening Expert Reports due by 1/6/2023. Responsive Expert Reports due by 2/10/2023. Reply Expert Reports due by 3/10/2023. Signed by Judge Colm F. Connolly on 12/13/2022. (kmd) (Entered: 12/13/2022) (3) |
| Dec 12, 2022 | 122 | STIPULATION TO EXTEND TIME Exchange of Expert Reports to January 6, 2023 - filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) (Entered: 12/12/2022) (3) |
| Dec 8, 2022 | 121 | NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.s Second Supplemental Objections and Responses to Plaintiffs First Set of Interrogatories filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) (Entered: 12/08/2022) (2) |
| Dec 7, 2022 | 119 | Joint STIPULATION regarding U.S. Patent No. 11,103,483 by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Entered: 12/07/2022) (6) |
| Dec 7, 2022 | 120 | SO ORDERED, re 119 Joint STIPULATION regarding U.S. Patent No. 11,103,483, filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. Signed by Judge Colm F. Connolly on 12/7/2022. (kmd) (Entered: 12/07/2022) (6) |
| Nov 22, 2022 | 117 | NOTICE OF SERVICE of 1. Teva Pharmaceuticals International GmbH and Cephalon LLC's Objections and Responses to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Second Set of Requests for Production of Documents and Things (Nos. 125 - 140) 2. Plaintiffs' Objections and Responses to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Second Set of Interrogatories (Nos. 10 - 15) 3. Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon LLC's Objections and Responses to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s First Set of Requests for Admission (Nos. 1 - 10) filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) (Entered: 11/22/2022) (3) |
| Nov 22, 2022 | 118 | SO ORDERED, re 116 Stipulation that the parties may conduct the previously noticed depositions after the November 18, 2022 close of fact discovery, filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. Signed by Judge Colm F. Connolly on 11/22/2022. (kmd) (Entered: 11/22/2022) (3) |
| Nov 18, 2022 | 115 | NOTICE OF SERVICE of (1) Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Requests for Admission (Nos. 1-10), and (2) Eagle Pharmaceuticals, Inc.'s Responses and Objections to Defendants' Second Set of Requests for Production of Documents and Things (Nos. 125-140) filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) (Entered: 11/18/2022) (3) |
| Nov 18, 2022 | 116 | Joint STIPULATION that the parties may conduct the previously noticed depositions after the November 18, 2022 close of fact discovery by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Entered: 11/18/2022) (3) |
| Nov 16, 2022 | 112 | Official Transcript of Markman Hearing held on September 15, 2022 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/7/2022. Redacted Transcript Deadline set for 12/19/2022. Release of Transcript Restriction set for 2/14/2023. (nmf) (Entered: 11/16/2022) (84) |
| Nov 16, 2022 | 113 | NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.s First Supplemental Objections and Responses to Plaintiffs First Set of Interrogatories filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) (Entered: 11/16/2022) (2) |
| Nov 16, 2022 | 114 | NOTICE OF SERVICE of Defendants Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) (Entered: 11/16/2022) (2) |
| Nov 11, 2022 | 110 | NOTICE OF SERVICE of (1) Defendants Notice of Deposition of Scott L. Tarriff, (2) Defendants Notice of Deposition of Phillip Christopher Buxton, (3) Defendants Notice of Deposition of Anthony Drager, (4) Defendants Notice of Deposition of Nagesh R. Palepu, (5) Defendants Notice of Deposition of Srikanth Sundaram filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) (Entered: 11/11/2022) (2) |
| Nov 11, 2022 | 111 | NOTICE to Take Deposition of Mukesh Bothra filed by Cephalon, LLC, Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) (Entered: 11/11/2022) (2) |
| Nov 8, 2022 | 108 | MOTION for Pro Hac Vice Appearance of Attorney Daniel P. Shanahan and Angela X. Gao - filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Entered: 11/08/2022) (5) |
| Nov 8, 2022 | 109 | NOTICE OF SERVICE of Plaintiff Eagle Pharmaceuticals, Inc.'s Responses and Objections to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Notice of Rule 30(b)(6) Deposition filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) (Entered: 11/08/2022) (3) |
| Nov 7, 2022 | 106 | REDACTED VERSION of 101 Notice to Take Deposition, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (DiBenedetto, Emily) (Entered: 11/07/2022) (11) |
| Nov 7, 2022 | 107 | NOTICE OF SERVICE of Teva Pharmaceuticals International GmbH and Cephalon LLC's Responses and Objections to Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s Notice of Rule 30(b)(6) Deposition filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) (Entered: 11/07/2022) (2) |
| Nov 1, 2022 | 101 | [SEALED] NOTICE to Take Deposition of Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on November 11, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) (Entered: 11/01/2022) (0) |
| Nov 1, 2022 | 102 | NOTICE to Take Deposition of Jaya Ayyagari on November 16, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) (Entered: 11/01/2022) (2) |
| Nov 1, 2022 | 103 | NOTICE to Take Deposition of Nirmal Khati on November 15, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) (Entered: 11/01/2022) (2) |
| Nov 1, 2022 | 104 | NOTICE to Take Deposition of Narendra Sahu on November 15, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) (Entered: 11/01/2022) (2) |
| Nov 1, 2022 | 105 | NOTICE to Take Deposition of M. Sowjanya on November 16, 2022 filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) (Entered: 11/01/2022) (2) |
| Oct 20, 2022 | 100 | NOTICE OF SERVICE of Defendants Notice of Rule 30(b)(6) Deposition of Plaintiffs Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GMBH, and Cephalon Inc. filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) (Entered: 10/20/2022) (2) |
| Oct 19, 2022 | 99 | NOTICE OF SERVICE of (1) Defendants Second Set of Requests for the Production of Documents and Things (Nos. 125-140), (2) Defendants Second Set of Interrogatories (Nos. 10-15), and (3) Defendants First Set of Requests for Admission filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) (Entered: 10/19/2022) (2) |
| Sep 22, 2022 | 98 | CLAIM CONSTRUCTION ORDER re (95 in 1:22-cv-00042-CFC, 73 in 1:21-cv-00952-CFC, 97 in 1:21-cv-00695-CFC) Proposed Order filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 9/22/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC, 1:22-cv-00042-CFC(nmf) (Entered: 09/22/2022) (4) |
| Sep 21, 2022 | 97 | PROPOSED ORDER Claim Construction by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/21/2022) (4) |
| Sep 13, 2022 | 91 | SO ORDERED, re (66 in 1:21-cv-00952-CFC) (85 in 1:22-cv-00042-CFC) (90 in 1:21-cv-00695-CFC) STIPULATION TO EXTEND TIME to File Public Versions of the Joint Claim Construction Brief, Appendix to the Joint Claim Construction Brief, and Motion for Leave to File Sur-Reply to September 13, 2022, filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 9/13/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC, 1:22-cv-00042-CFC(kmd) (Entered: 09/13/2022) (4) |
| Sep 13, 2022 | 92 | MOTION for Pro Hac Vice Appearance of Attorney David Kowalski - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/13/2022) (5) |
| Sep 13, 2022 | 93 | REDACTED VERSION of 84 Joint Claim Construction Brief by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Entered: 09/13/2022) (30) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Main Document) (12) |
| Sep 13, 2022 | 95 | REDACTED VERSION of 86 MOTION for Leave to File by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Entered: 09/13/2022) (22) |
| Sep 13, 2022 | 96 | MOTION for Pro Hac Vice Appearance of Attorney Shannon M. Bloodworth - filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) (Entered: 09/13/2022) (4) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Exhibit 1-4) (30) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Exhibit 5-10) (30) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Exhibit 11-20) (30) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Exhibit 21-30) (30) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Exhibit 31-40) (30) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Exhibit 41-48) (30) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Exhibit 49-52) (15) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Exhibit 53-60) (30) |
| Sep 13, 2022 | 94 | REDACTED VERSION of 85 Appendix, by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(Hoeschen, Nathan) (Entered: 09/13/2022) (Exhibit 61-73) (30) |
| Sep 9, 2022 | 88 | CLAIM Construction Chart by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A - 483 Patent, # 2 Exhibit B- 887 Patent)(DiBenedetto, Emily) (Entered: 09/09/2022) (Main Document) (19) |
| Sep 9, 2022 | 89 | Letter to Chief Judge Colm F. Connolly from Emily S. DiBenedetto regarding claims to be construed by the court. (DiBenedetto, Emily) (Entered: 09/09/2022) (2) |
| Sep 9, 2022 | 90 | STIPULATION TO EXTEND TIME to file public versions of the Joint Claim Construction Brief, Appendix and Motion for Leave to File Sur-Reply to September 13, 2022 - filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (DiBenedetto, Emily) (Entered: 09/09/2022) (4) |
| Sep 9, 2022 | 88 | CLAIM Construction Chart by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A - 483 Patent, # 2 Exhibit B- 887 Patent)(DiBenedetto, Emily) (Entered: 09/09/2022) (Exhibit A - 483 Patent) (13) |
| Sep 9, 2022 | 88 | CLAIM Construction Chart by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A - 483 Patent, # 2 Exhibit B- 887 Patent)(DiBenedetto, Emily) (Entered: 09/09/2022) (Exhibit B- 887 Patent) (18) |
| Sep 7, 2022 | 87 | ORDER: Having read the parties' claim construction briefing (D.1. 84) and having reviewed the December 15, 2020 hearing transcript and related briefing in Eagle Pharms. Inc. v. Hospira, Inc., C.A. No. 18-1074-CFC-CJB, I will construe the claim term "a non-aqueous liquid composition" to mean "a solution in which water does not make up a substantial portion and is not a significant solvent." Oral argument for the upcoming Markman Hearing will focus solely on the disputed term "ready to use" and will be limited to one hour. Signed by Judge Colm F. Connolly on 9/7/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC, 1:22-cv-00042-CFC(nmf) (Entered: 09/07/2022) (2) |
| Sep 2, 2022 | 84 | [SEALED] JOINT CLAIM CONSTRUCTION BRIEF filed by Teva Pharmaceuticals International GmbH, Cephalon, LLC. (DiBenedetto, Emily) (Entered: 09/02/2022) (0) |
| Sep 2, 2022 | 85 | [SEALED] Joint APPENDIX re 84 Joint Claim Construction Brief by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit 1-4, # 2 Exhibit 5-10, # 3 Exhibit 11-20, # 4 Exhibit 21-30, # 5 Exhibit 31-40, # 6 Exhibit 41-48, # 7 Exhibit 49-52, # 8 Exhibit 53-60, # 9 Exhibit 61-73)(DiBenedetto, Emily) (Entered: 09/02/2022) (0) |
| Sep 2, 2022 | 86 | [SEALED] MOTION for Leave to File - filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH. (Attachments: # 1 Exhibit A- Proposed Order, # 2 Exhibit B- Plaintiffs' Sur-Sur-Reply, # 3 Exhibit C)(Hoeschen, Nathan) (Entered: 09/02/2022) (0) |
| Sep 1, 2022 | 83 | STIPULATION and [Proposed] Order regarding Joint Claim Construction Brief by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/01/2022) (4) |
| Aug 29, 2022 | 82 | SO ORDERED, re 80 Stipulation to change Cephalon, Inc. to Cephalon, LLC and Amend the Caption, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. Cephalon, LLC added; Cephalon, Inc. terminated. Signed by Judge Colm F. Connolly on 8/29/2022. (kmd) (Entered: 08/29/2022) (3) |
| Aug 26, 2022 | 80 | STIPULATION to change Cephalon, Inc. to Cephalon, LLC and Amend the Caption by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) (Entered: 08/26/2022) (3) |
| Aug 26, 2022 | 81 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd., Other Affiliate Cupric Holding Co. LLC for Cephalon, Inc. filed by Cephalon, Inc.. (Hoeschen, Nathan) (Entered: 08/26/2022) (3) |
| Aug 15, 2022 | 79 | NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(DiBenedetto, Emily) (Entered: 08/15/2022) (2) |
| Jul 11, 2022 | 78 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Teva Pharmaceuticals International GmbH.(DiBenedetto, Emily) |
| Jul 8, 2022 | 77 | SO ORDERED (5) Docket Text: SO ORDERED, re (54 in 1:21-cv-00952-CFC, 76 in 1:21-cv-00695-CFC) STIPULATION TO EXTEND TIME (1) Opening Clain Construction Brief (2) Answering Claim Construction Brief, (3) Reply Claim Construction Brief, and (4) Sur-Reply Claim Construction Brief to (1) July 11, 2022, (2) August 1, 2022, (3) August 15, 2022, and (4) August 29, 2022, filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 7/8/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC(kmd) |
| Jul 7, 2022 | 76 | Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME (1) Opening Clain Construction Brief (2) Answering Claim Construction Brief, (3) Reply Claim Construction Brief, and (4) Sur-Reply Claim Construction Brief to (1) July 11, 2022, (2) August 1, 2022, (3) August 15, 2022, and (4) August 29, 2022 - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) |
| Jul 5, 2022 | 73 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Objections and Responses to Defendant Dr. Reddy's Laboratories Ltd. and Dr. Reddy Laboratories, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-124) filed by Eagle Pharmaceuticals, Inc..(Silver, Daniel) |
| Jul 5, 2022 | 74 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s First Set of Interrogatories (Nos. 1-9) filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Jul 5, 2022 | 75 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Objections and Responses to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-124) filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Jun 17, 2022 | 70 | Main Document (18) Docket Text: CLAIM Construction Chart by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) U.S. Patent No. 9,572,887, # (2) U.S. Patent No. 11,103,483)(Joyce, Alexandra) |
| Jun 17, 2022 | 70 | U.S. Patent No. 9,572,887 (19) |
| Jun 17, 2022 | 70 | U.S. Patent No. 11,103,483 (13) |
| Jun 17, 2022 | 71 | Main Document (3) Docket Text: MOTION for Claim Construction - filed by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Word Count Certification, # (2) Text of Proposed Order)(Joyce, Alexandra) |
| Jun 17, 2022 | 71 | Word Count Certification (1) |
| Jun 17, 2022 | 71 | Text of Proposed Order (2) |
| Jun 17, 2022 | 72 | Motion for Miscellaneous Relief (4) Docket Text: MOTION to Adopt Proposed Claim Construction re [70] Claim Construction Chart - filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) |
| Jun 13, 2022 | 69 | SO ORDERED (3) Docket Text: SO ORDERED, re [68] STIPULATION TO EXTEND TIME to file the Joint Claim Construction Chart to June 17, 2022, filed by Dr Reddy's Laboratories Inc. Signed by Judge Colm F. Connolly on 6/13/2022. (kmd) |
| Jun 10, 2022 | 68 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to file the Joint Claim Construction Chart to June 17, 2022 - filed by Dr Reddy's Laboratories Inc.. (Stamoulis, Stamatios) |
| Jun 8, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [67] MOTION for Pro Hac Vice Appearance of Attorney Jonathan I. Tietz, filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Ordered by Judge Colm F. Connolly on 6/8/2022. (kmd) |
| Jun 7, 2022 | 66 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc. Answer to Plaintiffs First Set of Interrogatories and (2) Defendants Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.s Responses to Plaintiffs First Set of Request for Production filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) |
| Jun 7, 2022 | 67 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jonathan I. Tietz - filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) |
| May 31, 2022 | 65 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Identification of Claim Terms & Proposed Constructions filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Keller, Karen) |
| May 27, 2022 | 64 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Preliminary Disclosure of Proposed Claim Terms for Construction filed by Accord Healthcare Inc., Accord Healthcare Ltd., Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) |
| May 23, 2022 | 63 | SO ORDERED (3) Docket Text: SO ORDERED, re [62] STIPULATION TO EXTEND TIME for the Parties to Exchange Their Proposed Terms for Construction and Proposed Constructions to May 27, 2022, filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Signed by Judge Colm F. Connolly on 5/23/2022. (kmd) |
| May 20, 2022 | 62 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the Parties to Exchange Their Proposed Terms for Construction and Proposed Constructions to May 27, 2022 - filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) |
| May 19, 2022 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants First Set of Interrogatories (Nos. 1-9) and (2) Defendants First Set of Requests for the Production of Documents and Things (Nos. 1-124) filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) |
| May 13, 2022 | 60 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Invalidity Contentions for U.S. Patent Nos. 9,572,887 and 11,103,483 filed by Accord Healthcare Inc., Accord Healthcare Ltd., Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) |
| Apr 29, 2022 | 57 | Notice (Other) (2) Docket Text: NOTICE of Change of Address of Williams & Connolly LLP by Cephalon, Inc., Teva Pharmaceuticals International GmbH (Hoeschen, Nathan) |
| Apr 29, 2022 | 58 | Statement (2) Docket Text: STATEMENT Regarding Third-Party Litigation Funding by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 29, 2022 | 59 | Disclosure Statement (2) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Cephalon, Inc., Teva Pharmaceuticals International GmbH filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Apr 28, 2022 | 56 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs' First Set of Requests for Production to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. 2) Plaintiffs' First Set of Interrogatories to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Apr 21, 2022 | 55 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Angela C. Whitesell as Counsel by Eagle Pharmaceuticals, Inc. (Whitesell, Angela) |
| Apr 5, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The PROPOSED Amended Protective Order, filed by Teva Pharmaceuticals International GmbH on 4/4/2022, has been removed from the docket. The proposed order should be re-filed with corrected pagination. (kmd) |
| Apr 5, 2022 | 53 | Proposed Order (30) Docket Text: PROPOSED ORDER Amended Protective Order by Teva Pharmaceuticals International GmbH. (Golden, Ronald) |
| Apr 5, 2022 | 54 | Protective Order (30) Docket Text: AMENDED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 4/5/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC(kmd) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). (Taylor, Daniel) |
| Mar 29, 2022 | 52 | Scheduling Order (4) Docket Text: STIPULATED SCHEDULING ORDER: Joinder of Parties due by 5/18/2022. Amended Pleadings due by 5/18/2022. A Bench Trial is set for 5/1/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. See stipulated order for further details. Signed by Judge Colm F. Connolly on 3/28/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC(nmf) |
| Mar 15, 2022 | 51 | Answer to Counterclaim (14) Docket Text: ANSWER to [49] Answer to Amended Complaint, Counterclaim by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Mar 9, 2022 | 50 | Notice of Substitution of Counsel (2) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Eagle Pharmaceuticals, Inc.: Entry of appearance of attorney Daniel M. Silver. Attorney John W. Shaw, Esq., Karen E. Keller, Esq., and Nathan Hoeschen, Esq. terminated. (Silver, Daniel) |
| Feb 22, 2022 | 49 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [46] Amended Complaint, , COUNTERCLAIM against All Plaintiffs by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) |
| Feb 14, 2022 | 48 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Infringement Contentions filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Feb 8, 2022 | 46 | Main Document (21) Docket Text: AMENDED COMPLAINT against Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.- filed by Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH, Cephalon, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Hoeschen, Nathan) |
| Feb 8, 2022 | 46 | Exhibit A (18) |
| Feb 8, 2022 | 46 | Exhibit B (13) |
| Feb 8, 2022 | 47 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,103,483 B2 . (Hoeschen, Nathan) |
| Feb 8, 2022 | 46 | Amended Complaint* (1) |
| Feb 7, 2022 | 45 | SO ORDERED (2) Docket Text: SO ORDERED, re [44] Stipulation regarding First Amended Complaint, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/7/2022. (kmd) |
| Feb 4, 2022 | 44 | Main Document (2) Docket Text: STIPULATION [and Proposed Order] regarding First Amended Complaint by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Attachments: # (1) Exhibit 1 (First Amended Complaint), # (2) Exhibit 2 (Redline))(Hoeschen, Nathan) |
| Feb 4, 2022 | 44 | Exhibit 1 (First Amended Complaint) (52) |
| Feb 4, 2022 | 44 | Exhibit 2 (Redline) (68) |
| Jan 28, 2022 | N/A | Remark (0) Docket Text: Remark: [43] Stipulation and Order un-sealed per counsel's consent. (kmd) |
| Jan 27, 2022 | 43 | Stipulation and Order (4) Docket Text: STIPULATION AND ORDER re [41] STIPULATION of Dismissal of Complaint Counts I-VI, VIII-XX, and XXII-XXVIII and Counterclaim Counts I-VI, VIII-XX, XXIIXXXIV, and XXXVI-XXXXII. Signed by Judge Colm F. Connolly on 1/27/2022.This order has been emailed to local counsel. (kmd) Modified on 1/28/2022 (kmd). |
| Jan 25, 2022 | 42 | Letter (1) Docket Text: Letter to Chief Judge Connolly from Nathan R. Hoeschen - re [41] Stipulation of Dismissal. (Hoeschen, Nathan) |
| Jan 24, 2022 | 41 | Stipulation of Dismissal (4) Docket Text: STIPULATION of Dismissal of Complaint Counts I-VI, VIII-XX, and XXII-XXVIII and Counterclaim Counts I-VI, VIII-XX, XXIIXXXIV, and XXXVI-XXXXII by Eagle Pharmaceuticals, Inc.. (Hoeschen, Nathan) |
| Jan 18, 2022 | 39 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file an answering brief in response to Defendants Motion for Judgment on the Pleadings (D.I. 30) to January 25, 2022 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 18, 2022 | 40 | SO ORDERED (2) Docket Text: SO ORDERED, re [39] STIPULATION TO EXTEND TIME to file an answering brief in response to Defendants Motion for Judgment on the Pleadings (D.I. 30) to January 25, 2022, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Re-Set Briefing Schedule: re [30] MOTION for Judgment on the Pleadings. Answering Brief due 1/25/2022. Signed by Judge Colm F. Connolly on 1/18/2022. (kmd) |
| Jan 11, 2022 | 38 | SO ORDERED (2) Docket Text: SO ORDERED, re [37] STIPULATION TO EXTEND TIME to file an answering brief in response to Defendants' Motion for Judgment on the Pleadings (D.I. 30) to January 18, 2022, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Re-Set Briefing Schedule: re [30] MOTION for Judgment on the Pleadings. Answering Brief due 1/18/2022. Signed by Judge Colm F. Connolly on 1/11/2022. (kmd) |
| Jan 10, 2022 | 37 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file an answering brief in response to Defendants' Motion for Judgment on the Pleadings (D.I. 30) to January 18, 2022 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [36] Proposed Protective Order, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 1/7/2022. (kmd) |
| Jan 7, 2022 | 36 | Proposed Order (30) Docket Text: PROPOSED ORDER [Proposed] Protective Order by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 5, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alex M. Grabowski, Daniel G. Brown, Kenneth G. Schuler, and Marc N. Zubick for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Jan 4, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of D.I. [31] has been replaced with a corrected version per request of counsel to correct a page break error that occurred during the pdf conversion. (nmf) |
| Jan 4, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [35] MOTION for Pro Hac Vice Appearance of Attorney Daniel G. Brown, Kenneth G. Schuler, Marc N. Zubick and Alex Grabowski, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 1/4/2022. (kmd) |
| Jan 4, 2022 | 35 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daniel G. Brown, Kenneth G. Schuler, Marc N. Zubick and Alex Grabowski - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jan 3, 2022 | 33 | Redacted Document (30) Docket Text: REDACTED VERSION of [31] Opening Brief in Support, by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) |
| Jan 3, 2022 | 34 | Redacted Document (15) Docket Text: REDACTED VERSION of [32] Declaration by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) |
| Dec 27, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [29] STIPULATION TO EXTEND TIME to submit a proposed protective order to January 7, 2022, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 12/27/2021. (kmd) |
| Dec 27, 2021 | 29 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to January 7, 2022 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 27, 2021 | 30 | Main Document (2) Docket Text: MOTION for Judgment on the Pleadings - filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Attachments: # (1) Text of Proposed Order)(Stamoulis, Stamatios) |
| Dec 27, 2021 | 30 | Text of Proposed Order (2) |
| Dec 21, 2021 | 28 | ANDA Form (2) Docket Text: Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 31, 2021. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 9/30/2023. (Hoeschen, Nathan) |
| Dec 20, 2021 | 27 | SO ORDERED (2) Docket Text: SO ORDERED, re [24] STIPULATION TO EXTEND TIME to submit a proposed protective order to December 27, 2021, filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 12/20/2021. (kmd) |
| Dec 17, 2021 | 24 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed protective order to December 27, 2021 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Dec 17, 2021 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) 2. Plaintiffs Teva Pharmaceuticals International GmbH and Cephalon, Inc.'s Initial Disclosures Pursuant to the Delaware Default Standard for Discovery 3. Plaintiff Eagle Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed.R.Civ. P. 26(a)(1) 4. Plaintiff Eagle Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Delaware Default Standard for Discovery filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH.(Hoeschen, Nathan) |
| Dec 17, 2021 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Dr. Reddys Laboratories Inc. and Dr. Reddys Laboratories, Ltd. Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Defendants Dr. Reddys Laboratories Inc. and Dr. Reddys Laboratories, Ltd. Discovery Disclosures Pursuant to the District of Delawares Default Standard filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Stamoulis, Stamatios) |
| Nov 10, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel) |
| Nov 10, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 11/10/2021. (Taylor, Daniel) |
| Nov 9, 2021 | 22 | Scheduling Order (29) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 5/2/2022. Amended Pleadings due by 5/2/2022. Joint Claim Construction Brief due by 9/2/2022. A Markman Hearing is set for 9/15/2022 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 4/7/2023. A Final Pretrial Conference is set for 4/25/2023 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 5/1/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 11/8/2021. (nmf) |
| Nov 9, 2021 | 23 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove David M. Fry as co-counsel.. (Keller, Karen) |
| Nov 1, 2021 | 21 | Main Document (1) Docket Text: Letter to The Honorable Colm F. Connolly from Nathan R. Hoeschen regarding the case schedule and potential coordination - re [17] Order,,, Set Deadlines,,. (Attachments: # (1) [Proposed] Joint Scheduling Order)(Hoeschen, Nathan) |
| Nov 1, 2021 | 21 | [Proposed] Joint Scheduling Order (29) |
| Oct 29, 2021 | 20 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Stamatios Stamoulis on behalf of Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. (Stamoulis, Stamatios) |
| Oct 26, 2021 | 19 | SO ORDERED (2) Docket Text: SO ORDERED, re [18] STIPULATION TO EXTEND TIME to submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed to November 1, 2021 filed by Cephalon, Inc., Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 10/26/2021. (kmd) |
| Oct 22, 2021 | 18 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed to November 1, 2021 - filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Sep 23, 2021 | 17 | Order (1) Docket Text: ORDER, this case having been recently joined and ready for scheduling pursuant to Fed. R. Civ. P. 16 and as this case is listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before October 25, 2021, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 10/25/2021.) Signed by Judge Colm F. Connolly on 9/23/2021. (nmf) |
| Sep 8, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The filers of D.I. [16] have been modified in the text and the background to reflect that this document has been filed on behalf of Teva Pharmaceuticals International GmbH, Cephalon, Inc., and Eagle Pharmaceuticals, Inc. (nmf) |
| Sep 7, 2021 | 16 | Answer to Counterclaim (30) Docket Text: ANSWER to [15] Answer to Complaint, Counterclaim by Teva Pharmaceuticals International GmbH, Cephalon, Inc., and Eagle Pharmaceuticals, Inc.(Fry, David) Modified on 9/8/2021 (nmf). |
| Aug 18, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Brandon M. White and Autumn N. Nero for Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Aug 16, 2021 | 15 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint,, , COUNTERCLAIM against All Plaintiffs by Dr. Reddy's Laboratories Ltd., Dr Reddy's Laboratories Inc..(Stamoulis, Stamatios) |
| Jun 8, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher D. Jones for Dr Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Jun 7, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Maria A. Stubbings for Dr Reddy's Laboratories Inc. and Dr. Reddy's Laboratories Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Jun 4, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber and Ben Picozzi filed by Teva Pharmaceuticals International GmbH. Signed by Judge Colm F. Connolly on 6/4/2021. (fms) |
| Jun 4, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Adam D. Harber, Ben V. Picozzi, and David I. Berl for Teva Pharmaceuticals International GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Jun 3, 2021 | 14 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Adam D. Harber and Ben Picozzi - filed by Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| Jun 2, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Autumn N. Nero, Brandon White, Shannon M. Bloodworth, Maria A. Stubbings, and Christopher D. Jones filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. Signed by Judge Colm F. Connolly on 6/2/2021. (fms) |
| May 27, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [13] STIPULATION TO EXTEND TIME for defendant Dr. Reddy's Laboratories, Inc.'s to move, plead, or otherwise respond to plaintiff's Complaint to August 16, 2021 filed by Dr Reddy's Laboratories Inc. Signed by Judge Colm F. Connolly on 5/27/2021. (fms) |
| May 26, 2021 | 12 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Autumn N. Nero, Brandon White, Shannon M. Bloodworth, Maria A. Stubbings, and Christopher D. Jones - filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) |
| May 26, 2021 | 13 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for defendant Dr. Reddy's Laboratories, Inc.'s to move, plead, or otherwise respond to plaintiff's Complaint to August 16, 2021 - filed by Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. (Stamoulis, Stamatios) |
| May 19, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) |
| May 19, 2021 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Cephalon, Inc.: For Dr. Reddy's Laboratories Ltd. waiver sent on 5/18/2021, answer due 8/16/2021. (Hoeschen, Nathan) |
| May 19, 2021 | 11 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Stamatios Stamoulis on behalf of Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. (Stamoulis, Stamatios) |
| May 18, 2021 | 9 | Affidavit of Service (1) Docket Text: AFFIDAVIT of Service for Summons, Complaint and ancillary papers served on Dr. Reddy's Laboratories, Inc. on 05/17/2021, filed by Cephalon, Inc., Eagle Pharmaceuticals, Inc., Teva Pharmaceuticals International GmbH. (Hoeschen, Nathan) |
| May 13, 2021 | 1 | Main Document (66) Docket Text: COMPLAINT filed against Dr Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3614760.) - filed by Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc., Cephalon, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Civil Cover Sheet)(apk) |
| May 13, 2021 | 1 | Exhibit A (11) |
| May 13, 2021 | 1 | Exhibit B (9) |
| May 13, 2021 | 1 | Exhibit C (10) |
| May 13, 2021 | 1 | Exhibit D (10) |
| May 13, 2021 | 1 | Exhibit E (13) |
| May 13, 2021 | 1 | Exhibit F (12) |
| May 13, 2021 | 1 | Exhibit G (18) |
| May 13, 2021 | 1 | Exhibit H (13) |
| May 13, 2021 | 1 | Exhibit I (13) |
| May 13, 2021 | 1 | Exhibit J (13) |
| May 13, 2021 | 1 | Exhibit K (7) |
| May 13, 2021 | 1 | Exhibit L (8) |
| May 13, 2021 | 1 | Exhibit M (12) |
| May 13, 2021 | 1 | Exhibit N (13) |
| May 13, 2021 | 1 | Civil Cover Sheet (2) |
| May 13, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| May 13, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/6/20. Date of Expiration of Patent: 1/28/31.Thirty Month Stay Deadline: 10/6/2022. (apk) |
| May 13, 2021 | 4 | Patent/Trademark Report to Commissioner (3) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s)(SEE ATTACHED). (apk) |
| May 13, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries, Ltd. for Cephalon, Inc. filed by Cephalon, Inc..(apk) |
| May 13, 2021 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Eagle Pharmaceuticals, Inc. (apk) |
| May 13, 2021 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries, Ltd. for Teva Pharmaceuticals International GmbH filed by Teva Pharmaceuticals International GmbH. (apk) |
| May 13, 2021 | 8 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (apk) |
